An airway or lung stent is a type of endobronchial prosthesis of different materials which supports and preserves the patency of the void tubular airway structure. According to MarketStack, the Global Airway Stent/Lung Stent Market is expected to grow considerably during the forecasted period. Factors such as the increase in lung cancer and respiratory disease prevalence are expected to intensify the growth and demand for the airway stent and lung stent market in the forecasted period. Further, the high adoption of treatments such as endoscopic therapy, bronchoscopy and chemotherapies due to the increase in the geriatric population and the high prevalence of lung cancer are also expected to drive the global Airway Stent/Lung Stent market in the forecasted period. Furthermore, the increase in the incidence of COPD and post-tuberculosis stenosis and high investments by public and private organizations for the development of non-vascular stents are also expected to fuel the growth of the airway lung/stent market in the forecasted period. However, the decrease in the prevalence of tobacco smoking and easy availability of alternative treatments are expected to curb the growth of the airway stent and lung stent market, whereas the various complications associated with stents and the lack of healthcare professionals to operate the procedure can challenge the growth of the airway stent and lung stent market.

The surging prevalence of respiratory disorders and the rising rate of surgical intervention are propelling the market for minimally invasive treatment, further incorporating the need for lung stents. Airway stents are crucial in improving the quality of life for patients with respiratory conditions. Providing structural support to the airway they help alleviate symptoms such as shortness of coughing, breath, and wheezing. Depending on the patient's condition and treatment goals, these stents can be placed temporarily or permanently. The choice of stent material and design depends on various factors, such as the patient's anatomy, the underlying condition, and the physician's preference. Implementing these stents offers better patient compliance as white, aiding in maintaining optimal levels of vessel patency. Lung stent placement is among the favourable choices for treating malignant airway lesions due to their satisfactory clinical outcomes. Reduced surgical complications, shorter hospital stays, rapid recovery, and effective post-surgical pain management are other factors accelerating the treatment demand. Compared to traditional hospitals, ambulatory surgical facilities offer a shorter stay after surgery, and ambulatory surgical facilities are more inexpensive. Laryngeal stent placement is frequently required during laryngotracheal reconstruction surgery. Laryngeal stents are solid or flat tubes made of various materials with different sizes, forms, and textures. Stents are used as the first line of treatment for lumen collapse or to support a laryngeal or tracheal reconstruction effort to stop the collapse. Larynguat stents offer smooth, firm, conforming support in laryngeal tractures, laryngeal stenosis, and subglottic stenosis. Laryngeal stents are made of a particular hardness to support the issue without damaging it. These are compressible and bendable and follow the inner laryngeal contour.

North American region leads the airway stent and lung stent market owing to the strong presence of many hospitals, the rise in the prevalence of diseases and disorders, and the increase in the geriatric population. Asia-Pacific is predicted to grow significantly over the forecast period due to the rise in the need for treatment using stents. The need to care for the infected population by managing the infection with medical supplies is increasing. Respiratory support devices such as atomizers, oxygen generators, life-support machines, and monitors are among the significant medical devices used in clinical treatment. Furthermore, various materials can be used in stents, with different stents having different disease indications. Airway stents can be of two types, permanent or removable. These can be used after the pulmonary physician applies electrocautery, laser, balloon dilatation, or APC to increase the size of airway narrowing. By placing a stent, the airways remain open, allowing adequate airflow and the standard passage of secretions. The bronchial stents segment is predicted to register a steadily fast profit growth rate in the global airway stent/lung stent market. This is due to the increasing use of bronchial stents in treating hemoptysis with lung cancer and managing increasing dyspnea, leading to rising demand for these devices. Moreover, bronchial stents are preferred because they meet criteria including palliative symptom alleviation, small incision, and a lower risk of surgical hazards. This minimally invasive method is most frequently used to treat symptoms of malignant tumours blocking airways. Silicon stents effectively maintain airway patency and are associated with good tolerance and infrequent, rarely life-threatening complications. They are safe, cost-effective, and easier to manipulate than other stents with different materials. The silicon stents come in balloon-expandable and expandable versions. These stents have been helpful in patients suffering from benign and cancer-related tracheobronchial strictures. The silicon stent segment is likely to witness growth during the forecast period. Silicone stents are a better option as they are simpler to remove and less likely to damage a future procedure. Increasing healthcare expenditure and awareness among people are also contributing to the market. Additionally, technological developments such as the growth of innovative stents that can provide real-time data of the respiratory tract using excellent technologies such as IoT and Data Science are also adding to the development of the global airway stenting market during the forecasted period. Developing biodegradable and drug-eluting lung stents will also elevate the adoption of airway stents, thus augmenting the growth of the Airway Stent/Lung Stent Market in the forecasted period.

The market players are Boston Scientific Corporation, TAEWOONG, MICRO-TECH EUROPE, and Merit Medical Systems.

In June 2022, Boston Scientific offered USD 230 million for M.I.Tech, a Korean maker of gastrointestinal and airway stents. The buyout will likely hand over about 64% of the company to Boston Scientific.

In February 2022, Micro-Tech Endoscopy introduced the first self-expanding tracheobronchial nitinol Y-shaped stent. The Y-shaped tracheal Stent System is planned to be a flexible, compliant device to aid in treating malignant neoplasms at the tracheobronchial carina.

Global Airway Stent/Lung Stent Market report provides deep insight into the Industrial market's current and future state across various regions. The study comprehensively analyses the Global Airway Stent/Lung Stent Market by segmenting based on Type (Tracheobronchial Stents, Laryngeal Stents), Product Type (Self-Expandable Stents, Non-Expandable Stents, Balloon-Expandable Stents), Material (Metal Stents, Silicone Stents, Hybrid Stents), End User (Hospitals, Ambulatory Surgery Centers), and Geography (Asia-Pacific, North America, Europe, South America, and the Middle East & Africa). The report examines the market drivers and restraints and the impact of COVID-19 on market growth in detail. The study covers emerging market trends, development, opportunities, and challenges in the industry. This report also covers extensively researched competitive landscape sections with prominent companies and profiles, including their market shares and projects.